|
|
In this panel, experts discuss challenges like scalability, regulation, and data standardization in immune cell therapy. They explore automation's impact and the rise of closed-system cell manufacturing. Watch now to gain insights into this evolving field. |
|
|
|
Delve into this comprehensive study aiming to identify the ideal concentrations of IL-7 and IL-15 for T cell expansion. Discover strategies to achieve the desired phenotype while minimizing protein usage, offering valuable insights into optimizing immune cell therapies. |
|
|
|
Examine the findings from clinical trials where multi-antigen targeted (MultiTAA) cell therapy was used to treat patients with acute myeloid leukemia (AML) and non-Hodgkin lymphoma (NHL). Learn more about this T cell therapy approach and how it's enhanced patient outcomes. |
|
|
|
This study tests a commercially available, non-viral transposase-based editing platform on its ability to overcome current viral limitations and outperform other transposases in terms of transposition efficiency in immune cells for both RUO and clinical applications. |
|
|
|
Explore the use of G-Rex® bioreactors for large-scale, low-cost immune cell therapy manufacturing, as well as compare a "fill-and-forget" workflow to a traditional mid-point cytokine spike workflow to reveal improved T cell expansion, viability, phenotypes, and more. |
|
|
